BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

885 related articles for article (PubMed ID: 17960567)

  • 1. Immortalized mouse articular cartilage cell lines retain chondrocyte phenotype and respond to both anabolic factor BMP-2 and pro-inflammatory factor IL-1.
    Majumdar MK; Chockalingam PS; Bhat RA; Sheldon R; Keohan C; Blanchet T; Glasson S; Morris EA
    J Cell Physiol; 2008 Apr; 215(1):68-76. PubMed ID: 17960567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immortalized cell lines from mouse xiphisternum preserve chondrocyte phenotype.
    Majumdar MK; Chockalingam PS; Bhat RA; Sheldon R; Keohan C; Blanchet T; Glasson S; Morris EA
    J Cell Physiol; 2006 Nov; 209(2):551-9. PubMed ID: 16883582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of a human articular cartilage-derived chondrocyte cell line that retains chondrocyte phenotype.
    Hoffman BE; Newman-Tarr TM; Gibbard A; Wang S; Hanning C; Pratta MA; Boyle RJ; Kumar S; Majumdar MK
    J Cell Physiol; 2010 Mar; 222(3):695-702. PubMed ID: 20020445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture.
    Sailor LZ; Hewick RM; Morris EA
    J Orthop Res; 1996 Nov; 14(6):937-45. PubMed ID: 8982137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
    Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
    Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dedifferentiated chondrocytes cultured in alginate beads: restoration of the differentiated phenotype and of the metabolic responses to interleukin-1beta.
    Lemare F; Steimberg N; Le Griel C; Demignot S; Adolphe M
    J Cell Physiol; 1998 Aug; 176(2):303-13. PubMed ID: 9648917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic stability of articular chondrocytes in vitro: the effects of culture models, bone morphogenetic protein 2, and serum supplementation.
    Stewart MC; Saunders KM; Burton-Wurster N; Macleod JN
    J Bone Miner Res; 2000 Jan; 15(1):166-74. PubMed ID: 10646126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1beta.
    Robbins JR; Thomas B; Tan L; Choy B; Arbiser JL; Berenbaum F; Goldring MB
    Arthritis Rheum; 2000 Oct; 43(10):2189-201. PubMed ID: 11037878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1beta.
    Kaiser M; Haag J; Söder S; Bau B; Aigner T
    Arthritis Rheum; 2004 Nov; 50(11):3535-40. PubMed ID: 15529348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant bone morphogenetic protein-4, transforming growth factor-beta 1, and activin A enhance the cartilage phenotype of articular chondrocytes in vitro.
    Luyten FP; Chen P; Paralkar V; Reddi AH
    Exp Cell Res; 1994 Feb; 210(2):224-9. PubMed ID: 8299720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1beta, but not BMP-7 leads to a dramatic change in the gene expression pattern of human adult articular chondrocytes--portraying the gene expression pattern in two donors.
    Saas J; Haag J; Rueger D; Chubinskaya S; Sohler F; Zimmer R; Bartnik E; Aigner T
    Cytokine; 2006 Oct; 36(1-2):90-9. PubMed ID: 17161615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular phenotyping of human chondrocyte cell lines T/C-28a2, T/C-28a4, and C-28/I2.
    Finger F; Schörle C; Zien A; Gebhard P; Goldring MB; Aigner T
    Arthritis Rheum; 2003 Dec; 48(12):3395-403. PubMed ID: 14673991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
    Andriamanalijaona R; Kypriotou M; Baugé C; Renard E; Legendre F; Raoudi M; Boumediene K; Gatto H; Monginoux P; Pujol JP
    J Rheumatol; 2005 Oct; 32(10):1958-67. PubMed ID: 16206353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1.
    Majumdar MK; Wang E; Morris EA
    J Cell Physiol; 2001 Dec; 189(3):275-84. PubMed ID: 11748585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor 1-induced interleukin-1 receptor II overrides the activity of interleukin-1 and controls the homeostasis of the extracellular matrix of cartilage.
    Wang J; Elewaut D; Veys EM; Verbruggen G
    Arthritis Rheum; 2003 May; 48(5):1281-91. PubMed ID: 12746901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced matrix synthesis and in vitro formation of cartilage-like tissue by genetically modified chondrocytes expressing BMP-7.
    Hidaka C; Quitoriano M; Warren RF; Crystal RG
    J Orthop Res; 2001 Sep; 19(5):751-8. PubMed ID: 11562118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of chondrocyte phenotype via baculovirus-mediated growth factor expression.
    Sung LY; Lo WH; Chiu HY; Chen HC; Chung CK; Lee HP; Hu YC
    Biomaterials; 2007 Aug; 28(23):3437-47. PubMed ID: 17467793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis.
    Studer RK; Georgescu HI; Miller LA; Evans CH
    Arthritis Rheum; 1999 Feb; 42(2):248-57. PubMed ID: 10025918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness of bovine chondrocytes to growth factors in medium with different serum concentrations.
    van Susante JL; Buma P; van Beuningen HM; van den Berg WB; Veth RP
    J Orthop Res; 2000 Jan; 18(1):68-77. PubMed ID: 10716281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of bone morphogenetic proteins 2, 4, 12, and 13 on the expression of cartilage and bone markers in the MC615 chondrocyte cell line.
    Valcourt U; Ronzière MC; Winkler P; Rosen V; Herbage D; Mallein-Gerin F
    Exp Cell Res; 1999 Sep; 251(2):264-74. PubMed ID: 10471312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.